January 8, 2015
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced that the African Orphan Crops Consortium (AOCC) is the 2015 recipient of the Agricultural Greater Good Initiative grant. African Orphan Crops Consortium plans to use the grant of Illumina reagents and consumables to further its work studying the genetic diversity of 100 different species of African [...]
NanoString Technologies Provides Update on 2014 Operational and Preliminary Financial Results
January 8, 2015
SEATTLE -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided an update on operational and preliminary financial results for the year ended December 31, 2014. Financial Highlights include: Total revenue for 2014 is expected to be in the range of $47.0 to $48.0 million, [...]
University of Michigan Appoints DNASTAR Exclusive Commercial I-TASSER Software Provider
January 8, 2015
MADISON, Wisconsin –– DNASTAR® announced today that it has been appointed by the University of Michigan as the exclusive provider of the award-winning I-TASSER structure prediction software to commercial entities worldwide. DNASTAR, which has had broad rights to distribute the I-TASSER software since 2012, will now be the sole authorized commercial distributor. The I-TASSER algorithms [...]
January 8, 2015
HILDEN, Germany, and GERMANTOWN, Maryland -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it had exceeded its goal for 250 new placements of the QIAsymphony modular automation solution in 2014, bringing the total number of cumulative placements to more than 1,250 at year-end. QIAGEN also announced its fifth U.S. regulatory decision [...]
MAAZ Standardizes on Industry Leading Informatics Solution
January 8, 2015
PHILADELPHIA -- Mohammad Abdullah Al Azzaz Company Limited (MAAZ) has implemented Thermo Scientific SampleManager LIMS, the leading Informatics solution for process industries worldwide, to enhance the services offered through the company’s contract testing laboratories. MAAZ, an ISO 17025:2005-approved laboratory by IAS U.S.A., is a strategic partner to key contractors in the Middle East focused on [...]
Horizon Discovery Group plc Acquires Haplogen Genomics GmbH
January 8, 2015
Cambridge, UK and Vienna, Austria -- Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Company"), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has agreed to acquire Haplogen Genomics GmbH, a biotechnology company based in Vienna, Austria [...]
Harvard Bioscience Acquires All Operations of HEKA Electronik
January 8, 2015
HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has acquired all of the operations of HEKA Elektronik, or HEKA, a privately held biomedical instrumentation and software business with headquarters in Germany, for a total of approximately $6 [...]
Appointment of non-executive directors
January 7, 2015
Cambridge, UK -- Sphere Medical Holding plc (AIM: SPHR.L) (“Sphere Medical” or the “Company”), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, today announces the appointment of Dr David Martyr and Meinhard Schmidt to the Company’s Board as Non-Executive Directors with immediate effect. Dr Martyr has held several senior [...]
Oxford Instruments shines a new light on optical spectroscopy
January 7, 2015
Oxford Instruments has launched a new Cryofree® optical cryostat – the Optistat™Dry – specifically designed for low temperature spectroscopy applications. Its unique design makes it the most versatile and flexible cryostat on the market. The OptistatDry allows optical spectroscopists to cool their samples to less than 3 Kelvin without the need for liquid cryogens. Low [...]
January 7, 2015
Germantown, Maryland, and Hilden -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the CE product launch of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth generation of the most accurate test for detecting tuberculosis (TB) infections. QFT-Plus builds on the legacy of QuantiFERON-TB Gold, which was the third-generation version of this important technology that [...]

